AbbVie ABBV

NYS: ABBV | ISIN: US00287Y1091   8/12/2025
223,12 USD (-1,31%)
(-1,31%)   8/12/2025
Grafiek AbbVie Inc. Grafiek AbbVie Inc.

AbbVie Inc. in het nieuws

2 december 2025 · AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers · Persbericht

2 december 2025 · À l'occasion du 19e Congrès européen sur les céphalées, AbbVie va présenter les données de la phase 3 d'ECLIPSE démontrant la supériorité de l'atogépant (AQUIPTA®) par rapport au placebo dans le soulagement complet de la douleur pour le traitement aigu de la migraine · Persbericht

24 november 2025 · AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference · Persbericht

18 november 2025 · AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma · Persbericht

14 november 2025 · AbbVie Partners with Award-Winning Filmmaker on Film About the Dynamic and Resilient Lives of Those Living with Blood Cancer · Persbericht

13 november 2025 · AbbVie Announces 20 Recipients of Migraine Career Catalyst Award™ · Persbericht

12 november 2025 · Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence · Persbericht

31 oktober 2025 · AbbVie Reports Third-Quarter 2025 Financial Results · Persbericht

29 oktober 2025 · The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year · Persbericht

29 oktober 2025 · AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo · Persbericht

Profiel AbbVie Inc.

Fabricage van farmaceutische preparaten
Farmaceutica
Gezondheidstechnologie
Productie

Website: www.abbvie.com

Hoofdzetel: North Chicago, Illinois vlag Verenigde Staten

Mijn selecties